VP Biden to AACR: Help me help youApril 21, 2016Patient & Survivor CareCLLCMLIndolent LymphomaBusiness of Medicine
FDG-PET guides need for eBEACOPP in advanced Hodgkin’sApril 12, 2016Indolent LymphomaAggressive LymphomasHodgkin Lymphoma
CUDC-907 enters phase II for relapsed or refractory lymphoma and multiple myelomaApril 12, 2016Indolent LymphomaTranslational Research
OTX015 dose for lymphoma narrowed in phase 1 studyApril 10, 2016Indolent LymphomaAggressive LymphomasMultiple Myeloma
Feds advance cancer moonshot with expert panel, outline of goalsApril 5, 2016CMLCLLIndolent LymphomaMultiple Myeloma
Follicular lymphoma: Quantitative PET/CT measures for detecting bone marrow involvementMarch 10, 2016Indolent Lymphoma
Expert panel issues guidelines for treatment of hematologic cancers in pregnancyDecember 1, 2015CMLAggressive LymphomasAMLIndolent Lymphoma
New therapies finding their place in management of follicular lymphomaNovember 5, 2015Indolent Lymphoma
Medical Roundtable: Hodgkin Lymphoma - Discussing Recent Evidence & Practice OptionsOctober 19, 2015Indolent LymphomaAggressive LymphomasHodgkin Lymphoma
Obinutuzumab trends better than rituxumab in relapsed indolent lymphomaSeptember 3, 2015Indolent Lymphoma
Lenalidomide + rituximab combo effective in recurrent follicular lymphomaAugust 24, 2015Indolent Lymphoma
